Ligand binding assay

Comparison of Hybrid LCMS & Ligand Binding Assays for Bioanalysis, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, April 5, 2021

TORONTO, April 5, 2021 /PRNewswire-PRWeb/ -- Historically, bioanalytical support for large molecule development has utilized ligand binding (LBA) technologies.

Key Points: 
  • TORONTO, April 5, 2021 /PRNewswire-PRWeb/ -- Historically, bioanalytical support for large molecule development has utilized ligand binding (LBA) technologies.
  • Hybrid mass spectrometry only requires one reagent for enrichment and this reagent does not need to be extremely selective.
  • In the past, our ligand binding team provided the majority of our large molecule bioanalysis support.
  • For more information, or to register for this event, visit Comparison of Hybrid LCMS & Ligand Binding Assays for Bioanalysis.

LBA and Hybrid LCMS Quantitation of Biotherapeutics and Biomarkers, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, June 22, 2020

However, the use of mass spectrometry in this field has gained a lot of momentum in the last several years.

Key Points: 
  • However, the use of mass spectrometry in this field has gained a lot of momentum in the last several years.
  • This now necessitates the question "How do you choose which approach to use (LBA or MS)?"
  • For the LBA, we will discuss the different types of ligand binding assays, answers to common questions that can lead to performing LBA vs. hybrid LCMS and some advantages of LBA over LCMS methodologies.
  • For more information or to register for this event, visit LBA and Hybrid LCMS Quantitation of Biotherapeutics and Biomarkers .